Itraconazole and terbinafine are both antifungal medications used to treat a variety of fungal infections
Oral terbinafine, itraconazole, and griseofulvin and topical ciclopirox 8% nail lacquer, efinaconazole 10% solution, and tavaborole 5% solution are approved by the Food and Drug Administration for treatment of onychomycosis in the United States and amorolfine 5% nail lacquer is approved in Europe
Design Long-term prospective follow-up study To compare the efficacy of either terbinafine or itraconazole orally versus the combination of the two drugs in the treatment of recalcitrant dermatophytosis
Common side effects include nausea, vomiting, diarrhea, rash and hypokalemia
Fluconazole is an effective antifungal agent that may be used to treat certain fungal or yeast infections
They confirm that terbinafine is somewhat more effective than itraconazole
Objective: To evaluate the efficacy and safety of the oral antifungal agents griseofulvin, ketoconazole, itraconazole, fluconazole and terbinafine in the treatment of S
In order to comprehend the intricate emerging scenario, an endeavor has been made to form a distinct outline in the shape of an overview on several of their facets
Both of these drugs have been shown to be more effective than griseofulvin in dermatophyte onychomycosis, and therefore the optimum choice of treatment lies between terbinafine and itraconazole
• 2 yr
Terbinafine, an allylamine, exhibits fungicidal action against dermatophytes, yeasts, and molds
All drugs significantly elevated ALP levels after 14 days and 28 days of treatment (p < 0